Managing Acquired C1 Inhibitor Deficiency (AAE-C1-INH) in Patients Undergoing Dental, Medical, Obstetric or Surgical Procedures
Patients with confirmed acquired angioedema secondary to C1 esterase inhibitor deficiency (AAE-C1-INH) face an elevated risk when a planned procedure is scheduled. A structured prophylactic approach before the procedure is indicated in this clinical setting.
Confirmed diagnosis of acquired angioedema secondary to C1 esterase inhibitor deficiency (AAE-C1-INH); patient is scheduled to undergo a dental, medical, obstetric or surgical procedure.
These patients are eligible for prophylaxis with C1-esterase inhibitor administered before the procedure is carried out.
Agent selection, timing and the full procedural protocol are set out in the structured regimen — available via the link below.
References
Patients with AAE-C1-INH are eligible for prophylaxis with C1-esterase inhibitor before undergoing dental, medical, obstetric or surgical procedures.